Vivimed Labs Ltd. - Research Center
532660 VIVIMEDLAB Group (Z) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Sales |
63.28 |
86.55 |
105.02 |
113.34 |
112.93 |
Operating profit |
-5.70 |
-18.24 |
-9.15 |
-0.07 |
28.36 |
Interest |
22.44 |
18.05 |
21.53 |
18.00 |
21.24 |
Gross profit |
-25.97 |
-36.06 |
-30.48 |
-17.01 |
9.85 |
EPS (Rs) |
-4.07 |
-5.31 |
-5.09 |
-3.08 |
0.21 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Other income |
2.17 |
0.23 |
0.20 |
1.06 |
2.72 |
Stock adjustment |
0.22 |
0.06 |
1.69 |
-1.20 |
3.86 |
Raw material |
34.71 |
51.00 |
69.33 |
73.59 |
45.73 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
15.16 |
12.34 |
16.65 |
15.03 |
13.26 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
18.89 |
41.39 |
26.51 |
26.00 |
21.73 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
8.97 |
8.04 |
8.93 |
8.52 |
7.89 |
Taxation |
-1.21 |
-0.05 |
2.82 |
- |
0.23 |
Net profit / loss |
-33.73 |
-44.04 |
-42.23 |
-25.52 |
1.72 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
16.58 |
16.58 |
16.58 |
16.58 |
16.58 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
-9.01 |
-21.07 |
-8.71 |
-0.06 |
25.11 |
GPM (%) |
-39.69 |
-41.55 |
-28.96 |
-14.87 |
8.51 |
NPM (%) |
-51.54 |
-50.75 |
-40.13 |
-22.31 |
1.49 |